Premature Expression of T Cell Receptor (Tcr)αβ Suppresses Tcrγδ Gene Rearrangement but Permits Development of γδ Lineage T Cells by Terrence, Kathleen et al.
 
The Journal of Experimental Medicine • Volume 192, Number 4, August 21, 2000 537–548
http://www.jem.org/cgi/content/full/192/4/537
 
537
 
Premature Expression of T Cell Receptor (TCR)
 
ab
 
 
Suppresses TCR
 
gd
 
 Gene Rearrangement but Permits 
Development of 
 
gd
 
 Lineage T Cells
 
By Kathleen Terrence, Christian P. Pavlovich, Errin O. Matechak, 
and B.J. Fowlkes
 
From the Laboratory of Cellular and Molecular Immunology, National Institutes of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0420
 
Abstract
 
The T cell receptor (TCR)
 
gd
 
 and the pre-TCR promote survival and maturation of early thy-
mocyte precursors. Whether these receptors also influence 
 
gd
 
 versus 
 
ab
 
 lineage determination
is less clear. We show here that TCR
 
gd
 
 gene rearrangements are suppressed in TCR
 
ab
 
 trans-
genic mice when the TCR
 
ab
 
 is expressed early in T cell development. This situation offers the
opportunity to examine the outcome of 
 
gd
 
 versus 
 
ab
 
 T lineage commitment when only the
TCR
 
ab
 
 is expressed. We find that precursor thymocytes expressing TCR
 
ab
 
 not only mature
 
in the 
 
ab
 
 pathway as expected, but also as CD4
 
2
 
CD8
 
2
 
 T cells with properties of 
 
gd
 
 lineage
cells. In TCR
 
ab
 
 transgenic mice, in which the transgenic receptor is expressed relatively late,
TCR
 
gd
 
 rearrangements occur normally such that TCR
 
ab
 
1
 
CD4
 
2
 
CD8
 
2
 
 cells co-express
TCR
 
gd
 
. The results support the notion that TCR
 
ab
 
 can substitute for TCR
 
gd
 
 to permit a 
 
gd
 
lineage choice and maturation in the 
 
gd
 
 lineage. The findings could fit a model in which lin-
eage commitment is determined before or independent of TCR gene rearrangement. How-
ever, these results could be compatible with a model in which distinct signals bias lineage choice
and these signaling differences are not absolute or intrinsic to the specific TCR structure.
Key words: lineage commitment • TCR transgenic mice • thymus • differentiation • positive 
selection
 
Introduction
 
The thymus is able to generate distinct types of mature T
cells that are differentiated for specific TCR recognition
and effector functions. Early in development, precursor
thymocytes rearrange and express the genes encoding
TCRs and mature as either 
 
ab
 
 or 
 
gd
 
 lineage T cells (for
reviews, see references 1, 2). The first T cells are 
 
gd
 
 lin-
eages that arise only in the fetal thymus. Each of these bears
a unique, canonical TCR and colonizes distinct epithelial
tissues of the periphery. The 
 
gd
 
 T cells that populate the
lymphoid organs have more diverse receptors and develop
in both the fetal and adult thymus. Lymphoid 
 
gd
 
 T cells
and precursors to the 
 
ab
 
 T cell lineage (bearing the pre-
TCR) appear roughly around the same time in the adult
thymus and are thought to derive from a common
CD4
 
2
 
CD8
 
2
 
 precursor. The productive rearrangement and
expression of the TCR
 
gd
 
 or of the pre-TCR (a het-
erodimer of TCR
 
b
 
 with invariant pT
 
a
 
) is critical for sur-
vival and further differentiation of these early thymocytes
(3). Of major interest is whether these receptors play a role
in 
 
ab
 
 versus 
 
gd
 
 lineage determination or only in the pro-
gression of already committed precursors (4, 5).
The pathways of 
 
ab
 
 and 
 
gd
 
 T cell development are quite
distinct. Although discrete stages of 
 
gd
 
 development have
not been identified, most 
 
gd
 
 lineage T cells never express
the CD4 or CD8
 
ab
 
 coreceptors and have no requirement
for MHC for maturation (6, 7). In contrast, precursor
 
CD4
 
2
 
CD8
 
2
 
 thymocytes expressing the pre-TCR prolifer-
ate, upregulate TCR
 
a
 
 rearrangement, and progress to a
CD4
 
1
 
CD8
 
1
 
 intermediate stage (3). If rearrangement of
TCR
 
a
 
 is productive, TCR
 
a
 
 replaces pT
 
a 
 
to form the ma-
ture TCR
 
ab
 
. Recognition of MHC by TCR
 
ab
 
 is re-
quired for the development of mature 
 
ab
 
 lineage T cells,
expressing either CD4 or CD8. The development of an ad-
 
ditional subset of 
 
ab
 
 T cells, the so-called NK T cells, is 
 
b
 
2
 
-
 
microglobulin (
 
b
 
2
 
m) dependent (8, 9). This minor
 
 
 
popula-
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g
 
/
 
d
 
 T Cell Development in TCR-
 
a
 
/
 
b
 
 Transgenic Mice
 
tion of T cells expresses either CD4 or no coreceptor, a re-
stricted TCR repertoire, and is not detected until after birth.
Although the lineage relationship of NK T cells to conven-
tional 
 
ab
 
 T cells is somewhat controversial, NK T cells
have characteristic phenotypic and functional properties that
clearly distinguish them from other T cell subsets (9).
With the advent of TCR
 
ab
 
 transgenic mice, a novel
population of TCR
 
ab
 
1
 
CD4
 
2
 
CD8
 
2 
 
(TCR
 
ab
 
DN)
 
1 
 
T cells
was observed (10–13). These cells appear early in the fetal
thymus, colonize both epithelial and lymphoid tissues, and
are especially prominent in TCR
 
ab
 
 transgenic mice under-
going strong negative selection. Naturally, questions arose as
to their origin and lineage relationship to other T cells.
There was speculation that these cells could be related to the
TCR
 
ab
 
1
 
CD4
 
2
 
CD8
 
2
 
 cells of wild-type mice (NK T cells)
or to the abnormal TCR
 
ab
 
1
 
CD4
 
2
 
CD8
 
2
 
 cells observed in
 
lpr
 
 mutant mice (14). Others suggested that they derive
from conventional 
 
ab
 
 T cells after the downregulation of
CD4 or CD8 (14, 15) or that they mature in the 
 
ab
 
 lineage
without ever expressing the CD4/CD8 coreceptors (16).
Evidence that the TCR
 
ab
 
DN T cells mature in a lin-
eage separate from conventional 
 
ab
 
 T cells came from
studies of transgenic HY TCR mice. In contrast to the
CD8 T cells of these mice, the TCR
 
ab
 
DN cells do not
express endogenous TCR
 
a
 
 genes, their TCR
 
d
 
 gene seg-
ments are not deleted (17), and they do not develop in
mice deficient for the common cytokine receptor 
 
g
 
 chain
(18). TCR
 
ab
 
DN cells mature in the absence of the select-
ing MHC and, most noteworthy, in HY TCR mice with a
pT
 
a
 
 null mutation (pT
 
a
 
2
 
/
 
2
 
), a few TCR
 
ab
 
DN cells co-
express endogenous TCR
 
gd
 
 and the transgenic TCR
 
ab
 
(17). Given these characteristics, it was proposed that
TCR
 
ab
 
DN cells of TCR
 
ab
 
 transgenic mice belong to
the 
 
gd
 
 lineage. In this model, the transgenic TCR
 
ab
 
 re-
places TCR
 
gd
 
 while still allowing 
 
gd
 
 lineage develop-
ment.
 
 
 
This model was contested, however, in an additional
report using DO11.10 TCR transgenic mice (16). Since
TCR
 
ab
 
DN cells required specific MHC for development,
the authors hypothesized that these cells were 
 
ab
 
 lineage T
cells that mature without passing through the CD4
 
1
 
CD8
 
1
 
intermediate stage of development.
In previous studies, there was only limited characteriza-
tion of TCR
 
ab
 
DN cells of TCRab transgenic mice,
making it difficult to determine their relationship to con-
ventional T cell subsets. As no single marker can distinguish
gd lineage T cells (with the exception of the TCR itself),
we examined TCRabDN cells using a number of criteria
(phenotype, function, development, and localization). An
analysis of several strains of TCRab transgenic mice reveals
that TCRabDN cells clearly exhibit characteristics of gd
lineage T cells. The MHC requirements for maturation
and the regulation of TCR gene rearrangement are dis-
tinctly different in TCRabDN cells than in conventional
ab lineage T cells. The results indicate that the premature
expression of TCRab allows thymocyte precursors to ma-
ture in the gd lineage. These findings have implications for
models of gd/ab lineage determination.
Materials and Methods
Mice. C57BL/6 (B6), C57BL/10 (B10), B10.A, B10.Q, and
B10.D2 mice were obtained from a National Institutes of Allergy
and Infectious Diseases contract to Taconic Farms, Inc., and
B10.BR and BALB/c, from The Jackson Laboratory. TCRab
transgenic mice were backcrossed, intercrossed, and selected as
described previously (19) to obtain H-2b, H-2k, H-2d, H-2q, H-2b
recombination activating gene (RAG)-22/2, H-2q RAG-22/2, or
H-2b MHC class II1/2CD41/2 AND TCR mice (20–23); H-2d
and H-2b class II2/2 DO11.10 TCR mice (24); and H-2d HA
TCR mice (25). H-2b and H-2d HY TCR mice (26) were ob-
tained by backcrossing 12 times to B10 and then to B10.D2;
H-2b and H-2k 5CC7 TCR mice, by crossing B6 5CC7 TCR
mice (27) to B10 or B10.A; and H-2b and H-2b class I2/2 P14
TCR mice (28), by backcrossing 10 times to B6 and then to
b2m2/2 (29). Except where noted, all TCRab transgenic mice
were on the positive-selecting MHC background: AND TCR
(H-2b or H-2k), 5CC7 TCR (H-2k), DO11.10 TCR (H-2d), HY
TCR (H-2b), and P14 TCR (H-2b). TCRgd transgenic mice in-
cluded the G8 TCR mice (H-2b b2m2/2) crossed and selected as
described (7), or H-2b TG78 TCR mice (30), backcrossed eight
times to B6.
Fetal mice were obtained from timed matings. The day of find-
ing a vaginal plug was designated as day 0 of embryonic develop-
ment. Mice were bred and maintained in a National Institutes of
Allergy and Infectious Diseases Research Animal Facility or on a
National Institutes of Allergy and Infectious Diseases contract to
Taconic Farms, Inc., according to American Association of Ac-
creditation of Laboratory Animal Care specifications. All proto-
cols for animal studies were approved by the National Institutes of
Allergy and Infectious Diseases Animal Care and Use Committee.
Cell Preparation, Antibodies, and Flow Cytometry. Cultured cell
lines used for these studies included: DN7.3 (TCRVg2/Vd5), a
mouse CD42CD82 T cell/BW5147 hybridoma, and DCEK, a
mouse L cell fibroblast line transfected with EaEbk. Thymocytes,
LNs, and LN T cells were prepared in single cell suspensions as
described previously (31). For enrichment of heat stable antigen
(HSA)lo (CD24lo) thymocytes, a culture supernatant of anti-HSA
(J11d) antibody was used with a 1:10 dilution of Lo-Tox–M rab-
bit complement (Cedarlane) and DNase (106 U/ml; Calbio-
chem). For magnetic bead isolation of CD42CD82 thymocytes
or LN T cells, 107 cells were reacted with 250 ml of purified
H129.19 and 53-6.7 (and RA3-6B2, for LN T cells) antibodies
(30 min, 48C). CD41CD81 cells were removed by treatment
with sheep anti–rat IgG-coated magnetic beads (30 min, 48C) at a
5:1 bead to cell ratio, using an MPC-1 magnetic particle concen-
trator (Dynal). This process was repeated at a 10:1 bead to cell ra-
tio. Epidermal lymphocytes were isolated and prepared in a single
cell suspension as described (32). Trypsinized surface antigens
were resynthesized in overnight culture with 20 U/ml recombi-
nant IL-2 (Genzyme). To enrich for viable cells, harvested cells
were incubated with biotin-labeled goat anti–hamster IgG (Cal-
tag) (30 min, 48C), washed twice, and bound to streptavidin-
coated magnetic beads (Miltenyi Biotech) (30 min, 48C). Cells
were passed over a MACS column (Miltenyi Biotech) and the
nonadherent fraction was collected.
1Abbreviations used in this paper: APC, allophycocyanin; b2m, b2-microglo-
bulin; B6, C57BL/6; B10, C57BL/10; CsA, cyclosporine A; HSA, heat
stable antigen; RAG, recombination activating gene; TCRabDN,
TCRab1CD42CD82.539 Terrence et al.
Antibodies and staining reagents included: anti–TCRb–FITC,
–PE or –allophycocyanin (APC) (H57-597), anti–gd TCR-
FITC, -PE, or unlabeled (GL3), anti-CD4–FITC, –PE, –APC,
or –CyChrome (RM4-5), anti-CD8a–CyChrome or unlabeled
(53-6.7), anti-CD8b.2–FITC (53-5.8), anti–IL-2Rb–FITC
(TM-b1), anti-NK1.1–PE (PK136), anti-CD5–FITC (53-7.3),
anti-Va11 TCR–FITC or unlabeled (RR8-1), anti-Va2–FITC
or –PE (B20.1), anti-Ab–FITC or –PE (AF6-120.1), anti-Ek–
FITC (14-4-45), anti–H-2Kd–FITC (SF1-1.1), anti–H-2Kk–
FITC (36-7-5), anti–H-2Kb–FITC (AF6-88.5), anti–H-2Kq–
FITC (KH-114), and anti-CD45R/B220–FITC, –PE, or unla-
beled (RA3-6B2), all obtained from BD PharMingen; anti-
CD8a–FITC, –PE, or –biotin (CT-CD8a), anti-CD4–biotin
(YTS 191.1), Thy 1.2–FITC or –PE (5a-8), streptavidin-APC or
-TriColor, goat anti–mouse IgG1–PE, goat anti–mouse IgG2a–
FITC, all obtained from Caltag; goat anti–rat IgG–FITC
(Kirkegaard & Perry); rat anti–mouse IgG1–FITC and streptavi-
din-FITC (Zymed Laboratories); and anti-CD24 (J11d), anti-HY
TCR (T3.70), anti-HA TCR (6.5), and anti-DO11.10 TCR
(KJ-126) culture supernatants.
Cells were stained and analyzed by flow cytometry and/or
electronically sorted using standard protocols (33). For some anal-
yses, cells were pretreated with an unlabeled anti-FcRg culture
supernatant (24G2) to block Fc receptor binding of the labeled
antibodies. Multicolor flow cytometry was performed on a
FACS® 440, FACSCalibur™, FACStarPlus™, or FACS Vantage™
(Becton Dickinson). Dead cells were excluded by light scatter
and propidium iodide gating. 150,000 events were collected for
three- and four-color analyses. For live-gated samples, 10,000–
20,000 CD42CD82 events were collected. Isolation of thy-
mocyte and LN T cell subsets by electronic cell sorting was per-
formed on a FACStarPlus™ (Becton Dickinson) or an EPICS 753
(Beckman Coulter).
For typing of transgenic or mutant mice, peripheral blood
lymphocytes were stained with labeled antibody to the appropri-
ate surface antigen, counterstained with Thy1.2 or B220 (used for
live gating for T or B cells, respectively). After staining, samples
were depleted of red blood cells with ACK lysing buffer (pH 7.4)
and analyzed by flow cytometry.
In Vitro TCR Stimulation for Proliferation, Induction of CD8aa
Expression, and IL-4 Secretion. For TCR stimulation, cells were
added to U-bottomed 96-well plates coated with anti-TCR anti-
bodies as described (31). Proliferation was determined on day 3 of
culture, measuring [3H]thymidine incorporation (1 mCi/ml pulse
for 18 h). Coexpression of CD8a and CD8b was assessed on day
4 of culture by flow cytometry. IL-4 production was assayed by
specific ELISA (34) using 100 ml of supernatant collected at day 3
of culture and stored at 2208C.
Radiation Bone Marrow Chimeras. Bone marrow chimeras
were made as described by reconstituting irradiated recipients
(1,000 rads, Cs source) with T-depleted bone marrow (19). For
the cyclosporine A (CsA) experiments, reconstituted mice re-
ceived daily intraperitoneal injections of 0.4 or 0.6 mg Sandim-
mune™ CsA (Sandoz) in 100 ml olive oil (Bertolli Classico) or of
100 ml olive oil only, starting on day 3 after reconstitution.
Quantitative PCR. T cell subsets were isolated by electronic
cell sorting. 105 sorted cells were digested using 13 PCR Buffer
(PerkinElmer), 2.5 mM MgCl2, 20 mg/ml proteinase K, 0.05%
Tween 20, and 20% InstaGene Matrix (Bio-Rad Laboratories) at
568C (2 h), followed by boiling (10 min). PCR was performed
using a reaction mixture containing 13 PCR Buffer (Perkin-
Elmer), 2.5 mM MgCl2, 200 mM each dNTP, 12.5 pmol each
primer, and 0.25 U native Taq polymerase (PerkinElmer) bound
to anti-Taq (CLONTECH Laboratories, Inc.). The total reaction
volume was 50 ml with 5 ml of DNA. Samples were incubated at
958C (5 min); amplified for 40 cycles at 948C (30 s), 568C (1
min), and 728C (1.5 min), and incubated at 728C (10 min) using
a 96-well plate in a PTC-100 thermocycler (MJ Research, Inc.).
Aliquots of 5 ml were removed every three cycles beginning at
cycle 18.
The following primers and probes were used: Vg2, TGTCCT-
TGCAACCCCTACCC; Jg1, TGTTCCTTCTGCAAATAC-
CTTG; Vg2 probe, GAGGAAGAAGACGAAGCTATC; 59
Cg1, TTACAGACAAAAGGCTTGAGTC; 39 Cg1, GTTCT-
CATGTTTGACAATACATCTG; and Cg1 probe, CTGAA-
GACTAACGACACATAC.
Quantitation was performed using a modified ELISA as de-
scribed (35). In brief, one primer for each gene was labeled with a
59 biotin moiety allowing capture of the PCR product on an avi-
din-coated plate. The second strand was denatured with 0.1 M
NaOH and an FITC-labeled probe was bound to the captured
strand. Bound probe was detected with an anti-FITC labeled
with alkaline phosphatase in the presence of substrate, CSPD
(Tropix). Chemiluminescence was measured using a luminome-
ter (Dynatech).
To estimate the relative frequency of Vg2–Jg1 rearrangements
in the experimental populations, a standard curve generated by ti-
trating DN7.3 cells (containing three Vg2–Jg1 rearrangements
per cell [36]) with DCEK fibroblast cells and amplifying the seri-
ally diluted samples in the same PCR. For each sample of 105
cells, a PCR ELISA was performed and the quantity of PCR
product (in light units) was determined as a function of cycle
number (18–39 cycles). Primers and probes specific for Cg1 were
used to normalize the amount of DNA present. Data from the lu-
minometer were fit to a logistic equation, and the parameters
were used to calculate the cycle value at half-maximum (C50) of
amplification (35). C50 values were plotted against the correspond-
ing log10 cell number of DN7.3 cells in each input sample and a
best-fit line was generated. C50 values for experimental samples
obtained in the same assay could be matched to this best-fit line to
estimate the relative frequency of Vg2–Jg1 rearrangements.
Results
CD42CD82 T Cells of TCRab Transgenic Mice Have
Properties of gd Lineage T Cells. Wild-type mice bear two
CD42CD82 subpopulations of mature T cells, one bearing
TCRab (referred to as NK T cells) and the other, TCRgd.
In contrast, an analysis for TCR on CD42CD82 T cells of
HY TCR (TCRab) transgenic mice reveals no TCRgd1
and a larger than usual population of TCRab1 cells (37).
Also in contrast to CD4 or CD8 ab lineage T cells, the
CD42CD82 T cells of HY TCR and 2B4 TCR transgenic
mice express only the transgenic TCRa and no endogenous
TCRa (17, 38). Because of these unusual features, we fur-
ther characterized the TCRabDN subset of AND TCR
and other TCR transgenic mice to assess lineage properties
relative to normal T cell subsets.
TCRabDN cells were analyzed for phenotype and
function and compared with the NK T, gd T, and the ma-
jor CD4 and CD8 ab T cell subsets of wild-type mice, as
well as CD42CD82TCRgd1 cells of TCRgd transgenic
mice (TG78) (30). As shown previously (8), freshly isolated
NK T cells of B6 mice (TCRabDN) express IL-2R540 g/d T Cell Development in TCR-a/b Transgenic Mice
(CD122) and NK 1.1, and produce high amounts of IL-4
in response to in vitro TCR stimulation (Fig. 1, A and B,
and Fig. 2). In contrast, the TCRabDN population of
AND TCR mice expresses lower levels of these markers
and produces no IL-4 (39; Fig. 1, A and B, and Fig. 2). The
TCRabDN cells also express relatively lower levels of
CD5, delineating this subset from mature CD4 and CD8 T
cells, but not from TCRgd1 T cells (Fig. 1 C). Together
these phenotypic and functional properties distinguish
TCRabDN cells from NK T and the major ab lineage,
but not from gd lineage T cells.
gd T cells appear early in adult T cell development, be-
fore the ab lineage T cells (40–42). To assess when the
TCRabDN cells arise in thymic development, we gener-
ated hematopoietic stem cell chimeras using bone marrow
from AND TCR mice to reconstitute irradiated recipients.
Between days 10 and 15 after reconstitution, we observed a
population of Va111CD42CD82 followed by Va111
CD41CD81 thymocytes. By days 18–20, mature CD41
CD82 thymocytes develop (data not shown). On day 15,
transgenic TCR1 (Va11) CD42CD82, and CD41CD81
thymocytes were sorted and stimulated in vitro using anti-
Va11 antibody (Fig. 3, a and b). The Va111CD42CD82
thymocytes are competent to incorporate [3H]thymidine in
response to anti-Va11 cross-linking while Va11-bearing
CD41CD81 thymocytes are not. Therefore, like gd T
cells, TCRabDN T cells appear well before the CD41
CD82 thymocytes and much earlier than NK T cells that
arise after the CD41CD82 and CD42CD81 thymocytes in
wild-type mice (8).
Previous studies (43–45) have indicated that the devel-
opment of the major ab T cell subsets (CD4/CD8), as well
as the minor TCRab1CD42CD82 (NK T) subset of
wild-type mice, are inhibited by CsA. gd lineage T cells
are relatively less sensitive. To further assess lineage proper-
ties, TCRabDN cells of AND TCR mice were tested for
sensitivity to CsA, administered over the course of adult T
cell development. Irradiated recipients reconstituted with
AND TCR bone marrow were treated daily with CsA for
5 wk, after reconstitution. As shown in Table I, the devel-
opment of Va111CD42CD82 TCR1 is up to 75-fold less
sensitive to CsA than are Va111CD41CD82 thymocytes.
These data indicate that TCRab1DN cells are relatively
resistant to CsA administered during development, as are
gd lineage T cells.
Since CD42CD82 TCRgd1 thymocytes of wild-type
mice can be induced to express CD8aa after in vitro acti-
vation (46; Fig. 4 c), we tested the ability of mature
Figure 1. Phenotypic markers distinguish the TCRabDN T cell sub-
set of TCRab transgenic mice from ab lineage T cells (CD4 and CD8),
NK T, but not from gd lineage T cells. Thymocytes (A and B) or B cell–
depleted lymph node T cells (C) from B6, transgenic TCRgd (TG78), or
transgenic TCRab (AND and P14) mice were each stained for TCRab,
TCRgd, CD4 and/or CD8, and a fifth marker (IL-2Rb, NK1.1, or
CD5), and analyzed by flow cytometry. The mean fluorescence intensity
for the specified markers was determined for CD4/CD8 single posi-
tive (SP) T cells by software gating for CD41CD82TCRabhi and
CD42CD81TCRabhi, or for CD42CD82 T cells, by live gating for
CD42CD82 followed by software gating for TCRab1 or TCRgd1.
Each bar represents the means (with SE bars) collected from analysis of
three individual mice with the exception of B6 (two mice).
Figure 2. TCRabDN T cells respond to anti-
TCR stimulation by proliferating but do not pro-
duce an IL-4 response. Lymph node CD42CD82
or CD41 T cells from AND TCR (Va11/Vb3),
CD4282TCRgd1 T cells from G8 TCR mice (pu-
rified using magnetic beads and electronic cell sort-
ing), or HSAlo B6 thymocytes (an enriched source
of NK T cells), plated at 5 3 104 cells/well, were
stimulated with 10 mg/ml immobilized anti-TCR
antibody (anti-Va11 for AND TCR, anti-TCRgd
for G8 TCR, and anti-TCRab for B6 TCR) and
assayed for (A) IL-4 production where 1 unit 5 0.5
pg of IL-4, and for (B) proliferation. Data are repre-
sentative of two experiments, averaging values from
triplicate wells, and are derived from dose–response
curves using 0.1–100 mg/ml of antibody.541 Terrence et al.
TCRabDN cells to make this response. As shown in Fig.
4, a and b, Va111CD42CD82, but not Va111CD41 T
cells, are induced to express CD8aa in response to anti-
TCR stimulation. Similar responses have been obtained
from TCRabDN splenocytes of TCRa transgenic mice
(39). Thus, by all of the criteria we examined, TCRabDN
cells are clearly distinguished from conventional ab lineage
and NK T cells, and most resemble gd lineage T cells.
TCRab DN Cells of TCRab Transgenic Mice Do Not Re-
quire MHC for Development. One of the hallmarks of ab
T cell development is the requirement for MHC-specific
positive selection (47). In contrast, gd T cells fully mature
in the absence of MHC (6, 7). Since there are conflicting
reports on the selection requirements of TCRabDN cells
(10, 12, 16), we tested several strains of TCRab transgenic
mice, bearing MHC class I– or class II–specific TCRs. As
shown in Fig. 5, the TCRabDN cells of five different
strains of TCRab mice develop equally well in the posi-
tively selecting or in the neutral (nonselecting) MHC back-
ground. Development is comparable both in percentage
(Fig. 5) and in absolute number (data not shown). Thus,
TCRabDN cells show no MHC dependence for develop-
ment, in clear contrast to mainstream ab lineage T cells
(CD42CD81 or CD41CD82) of the same mice that show
an absolute requirement for specific MHC. These findings
argue against the view that TCRabDN cells derive from
conventional CD4 or CD8 T cells by the downregulation
of a coreceptor.
TCRabDN Cells of Some Strains Coexpress Endogenous
TCRgd and Transgenic TCRab.  The analyses above in-
dicate that TCRabDN cells have gd lineage properties.
Therefore, CD42CD82 T cells of several strains of
TCRab transgenic mice were analyzed for expression of
TCRgd. An obvious population of CD42CD82 thy-
mocytes and peripheral T cells bearing only the transgenic
Figure 3. TCRabDN cells appear early in thymic de-
velopment. Thymocytes were harvested day 15 after re-
constituting B10.BR or B10.A RAG-22/2 irradiated re-
cipients with T-depleted H-2k AND TCR bone marrow.
(a) Cells were stained for CD4, CD8, and Va11 TCR and
analyzed by three-color flow cytometry. (b) Thymocytes
were electronically sorted for Va111CD41CD81 and
Va111CD42CD82. Sorted cells (12 3 104/well) were
tested in a proliferation assay for response to plate-bound
anti-Va11 (RR8-1) antibody. Proliferation data are repre-
sentative of two sorting experiments, and the cytometric
analysis on day 15 is representative from several series of
analyses performed on thymocytes from chimeric mice on
days 10–20 after reconstitution.
Table I. Effect of CsA on Developing Thymocyte Subsets
No. of thymocytes
Treatment Total CD42CD82 CD41CD81 CD41CD82
Oil 3.1 3 106 2.25 3 106 3.8 3 105 3.2 3 105
0.4 mg CsA/oil 1.4 3 106 1.1 3 106 1.7 3 105 3.2 3 104
Fold reduction 23 23 23 103
Oil 16.2 3 106 5.2 3 106 2.9 3 106 7.6 3 106
0.6 mg CsA/oil 1.5 3 106 1.1 3 106 2.6 3 105 2.0 3 104
Fold reduction 113 53 113 3803
Thymocytes were harvested at 5 wk after reconstitution, stained with
antibodies to CD4, CD8, and Va11, and analyzed by three-color flow
cytometry. The data are obtained from a minimum of four pooled
thymi and are representative of three experiments. Values are given in
absolute number of Va111 thymocytes recovered from chimeras (irra-
diated B10.BR or B10.A recipients reconstituted with H-2k AND
TCR bone marrow) after daily in vivo treatment with CsA.
Figure 4. TCR stimulation can
induce CD8aa expression on
TCRab DN T cells. (a) Va111
CD42CD82, (b) Va111CD41
lymph node T cells from AND
TCR mice (isolated by electronic
cell sorting and cultured at 4 3
104/well on 30 mg/ml plate-
bound anti-Va11, RR8-1, in the
presence of recombinant IL-1 and
IL-2, 100 U/ml, each), and (c)
CD42CD82 thymocytes of day 1
neonatal mice (isolated by mag-
netic bead depletion and cultured
at 10 3 104/well on 24 mg/ml
immobilized anti-gd, GL-3, in
the presence of rIL-1 and rIL-2,
20 U/ml each) were assayed for
expression of CD8a and CD8b
by flow cytometry. The data are
representative of three or more
experiments. B6 LN T cells were
used as a positive control for
CD8b staining (data not shown).542 g/d T Cell Development in TCR-a/b Transgenic Mice
TCRab was apparent in all of the mice analyzed. In some
strains, however, there existed a second subset of
CD42CD82 T cells coexpressing the transgenic TCRab
and endogenous TCRgd (Fig. 6 and Table II). This latter
subset bearing both TCRs was most prominent in the P14
TCR mice. It is noteworthy that like the TCRabDN sub-
set of AND TCR mice, both TCRabDN–bearing subsets
of P14 TCR mice exhibited properties of gd lineage T
cells (Fig. 1 and data not shown). It was previously reported
that TCRgd1 cells develop in P14 TCR mice (48); how-
ever, it was not appreciated that these T cells coexpress the
transgenic TCRab.
These different patterns of TCR expression prompted us
to investigate the timing of transgenic TCRab expression
during fetal thymic ontogeny, using the AND and P14
TCR mice as prototypes. As shown in Fig. 7, AND TCR
is expressed early on a majority of E14 thymocytes. In con-
trast, the P14 TCR is first detected around E15–16, and
then only on a minor subset of fetal thymocytes. These
data, considered together with the data from adult thy-
mocytes in Fig. 6, suggest that very early expression of the
transgenic TCRab inhibits endogenous TCRgd gene re-
arrangement and/or expression.
Endogenous TCRgd Gene Rearrangements Are Suppressed in
TCRabDN Cells of AND, but Not in TCRabDN Cells of
P14 TCR Mice. To determine the basis for differences in
TCR expression in TCRabDN cells of AND and P14
TCR mice, TCRgd gene rearrangements were examined
using a quantitative PCR assay. Since TCRVg2 is com-
monly used by lymphoid gd T cells (49), the frequency of
TCRVg2®Jg1 rearrangement was determined in mature
T cell subsets (Fig. 8). The analyses indicate that this gene
rearrangement is much more suppressed in TCR1CD42
Figure 5. TCRabDN cells do not require
MHC-dependent positive selection for develop-
ment. Thymocytes were isolated from MHC class
I–specific (HY and P14) or class II–specific (AND,
5CC7, and DO11.10) TCR transgenic mice bred
onto a positively selecting (pos) or nonselecting,
neutral (neut) MHC background. Cells were
stained for CD4, CD8, and TCR (using antibodies:
T370 for HY, anti-Va2 for P14, anti-Va11 for
AND and 5CC7, and KJ-126 for DO11.10 TCR).
The percent of transgenic (tg) TCRhi cells was
determined from analysis of total thymocytes by
software gating for CD42CD82, CD4281, or
CD41CD82. Each bar represents the mean per-
centage (with SE bars) of TCRhi of CD42CD82 or
of total thymocytes from analyses of three to six in-
dividual mice per group.
Table II. Coexpression of Transgenic TCRab and Endogenous 
TCRgd in CD42CD82 Thymocytes
Percentage of CD42CD82 thymocytes
Mice TCRab1TCRgd2 TCRab1TCRgd1 n
B6 12.5 (2.0) 0.06 (0.02) 8
AND 94.2 (9.2) 0.05 (0.01) 7
HY 94.5 (3.0) 0.06 (0.02) 7
HA 74.8 (9.6) 0.08 (0.04) 5
DO11.10 81.8 (4.9) 0.15 (0.04) 7
5CC7 80.7 (6.6) 0.56 (0.26) 6
P14 71.3 (5.4) 2.85 (0.54) 7
Thymocytes obtained from wild-type B6 or TCRab transgenic mice
were stained and analyzed by flow cytometry as shown in Fig. 6. Aver-
age values are given with SE in parentheses; n is the number of mice
analyzed of each type.543 Terrence et al.
CD82 (TCRabDN) cells of AND TCR than of P14
TCR mice. Similar differences between AND TCR and
P14 TCR mice were observed with other Vg and Vd gene
segments, although the rearrangement frequencies were
much lower (data not shown). Of note, the occurrence of
Vg2®Jg1 rearrangement in TCR1CD42CD82 T cells
of P14 TCR mice is equivalent to those of TCRgd1 cells
of G8 TCRgd (Vg21) transgenic mice and of B6 wild-
type mice (Fig. 8 a). Thus, in the P14 TCR mice that ex-
press the transgenic receptor relatively late, TCRgd rear-
rangement is uninhibited and TCRabDN cells bearing
TCRgd are observed (Figs. 6–8).
Interestingly, an analysis of the frequency of Vg2®Jg1
rearrangements in CD4 T cells of AND TCR mice is in-
creased in the semiselecting (class II1/2, CD41/2) or non-
selecting (H-2q) MHC background in comparison over the
frequency in the selecting MHC (H-2b) background (Fig. 8
b). These results fit with the notion that MHC engagement
terminates RAG expression during ab development (50).
In contrast, the TCRabDN cells developing in the
CD42CD82 (gd) pathway follow different rules since rear-
rangement frequency is independent of MHC (Fig. 8 a).
These findings suggest that TCR gene rearrangement is
differentially regulated in the gd and ab lineages.
TCRgd Is Expressed by Skin Lymphocytes of AND TCR
Mice. TCRgd gene rearrangements in thymocyte precur-
sors that localize to skin epithelium occur much earlier in
fetal development than those destined for migration and
residence in the lymphoid tissues (2). Therefore, there was
the possibility that the dendritic epidermal T lymphocytes
of AND TCR mice would express TCRgd since some of
their thymic precursors may have rearranged TCRgd be-
fore transgenic TCRab expression. In contrast to the lym-
phoid CD42CD82 T cells that fail to express TCRgd (Fig.
6), skin lymphocytes express two subsets of T cells (Fig. 9),
one expressing TCRab alone and the second expressing
both TCRab and TCRgd. Thus, when TCRab trans-
gene expression occurs after endogenous TCRgd rear-
rangements, rearrangement is not suppressed, and TCRgd
and TCRab can be expressed by the same cells. We deter-
mined in parallel analyses that these cells are CD42CD82,
Va111, Vb31, and Va31.
In the periphery of normal mice, the canonical Vg31
TCR is expressed exclusively on skin lymphocytes (2). The
finding that T cells, bearing the AND TCR and coexpress-
ing the expected TCRgd, can home at the right time to
what is normally a gd-specific site, provides additional evi-
dence that TCRabDN cells are gd lineage T cells. Presum-
ably, the skin lymphocytes expressing only the transgenic
TCRab have an out of frame TCRgd or, alternatively,
some cells express the transgenic TCR early enough to sup-
press endogenous TCRgd rearrangements. In any case, the
finding that even the TCRab1TCRgd2 subpopulation is
able to traffic to this traditionally gd-specific site demonstrates
that skin homing is not dependent on the canonical TCR.
These data, like those above, reveal that when the TCR is
expressed early (regardless of whether it is TCRgd or
TCRab), the receptor allows gd lineage commitment and
maturation in the gd lineage.
Discussion
These studies examine T cell development in transgenic
mice with premature expression of TCRab. An interesting
feature of the mice is a population of mature CD42CD82
thymocytes and peripheral T cells, expressing only the
transgenic TCRab (TCRabDN). To determine whether
TCRabDN cells belong to the ab or gd lineage, we ana-
lyzed these cells in several TCR transgenic strains and
compared them to the T cell subsets of normal mice. By all
criteria examined, the TCRabDN cells clearly exhibit
characteristics of gd lineage T cells. The lack of a corecep-
tor, the level of CD5, and the early maturation delineate
TCRabDN cells from the major TCRab1 CD4 and
CD8 T cell subsets. TCRabDN cells do not express
NK1.1 or IL-2Rb (CD122) or produce IL-4, distinguish-
Figure 6. CD42CD82 T cells of AND and HY TCR mice express
transgenic TCRab but no TCRgd, while those of P14 TCR mice coex-
press transgenic TCRab and endogenous TCRgd. Thymocytes and
lymph node cells, stained for TCRab (H57-597), TCRgd (GL3), CD4,
and CD8, were analyzed by flow cytometry using live gating to collect
data only from CD42CD82 cells. The numbers inside the quadrants rep-
resent the percentage of CD42CD82 thymocytes in each population. Sta-
tistics are given in Table II.544 g/d T Cell Development in TCR-a/b Transgenic Mice
ing them from the NK T cells of wild-type mice. In con-
trast, TCRabDN cells are similar to gd T cells since their
development is early, is relatively insensitive to CsA, and is
MHC independent. Also, like gd lineage cells, TCRabDN
cells can be induced to express CD8aa homodimers in re-
sponse to anti-TCR stimulation. Most notable, in TCRab
strains where the transgenic receptor is expressed later in
development, CD42CD82 T cells arise coexpressing the
transgenic TCRab and endogenous TCRgd (Table II,
and Figs. 6 and 7). TCRabDN cells with both receptors
exhibit the same phenotype and properties as those lack-
ing TCRgd expression. These findings provide the most
direct evidence that TCRabDN cells are gd lineage T
cells.
The different patterns of TCR expression in CD42CD82
T cells of TCRab mice appear to be related to the timing
of TCRab transgene expression with respect to endoge-
nous TCRgd gene rearrangement. As modeled in Fig. 10,
the early expression of transgenic TCRab in precursor
thymocytes of AND TCR mice causes suppression of en-
dogenous TCRgd gene rearrangement; nevertheless, the
transgenic receptor allows continued maturation in the
CD42CD82 (gd) pathway. In P14 TCR mice, the trans-
genic receptor is expressed later such that TCRgd gene
rearrangements occur normally. If rearrangements are
productive, mature CD42CD82 T cells emerge coexpress-
ing the TCRab (P14 TCR) and endogenous TCRgd
(Figs. 6–8, and Table II). The different TCR expression
patterns in skin versus lymph node CD42CD82 T cells of
AND TCR mice also can be explained by this model. A
subset of epidermal lymphocytes coexpresses the transgenic
TCRab and endogenous TCRgd (Fig. 9), but lymph
node T cells bear only the transgenic TCRab (Fig. 6).
Thus, the rearrangements of genes encoding the lymphoid
type TCRgd are suppressed by AND TCR expression,
whereas rearrangements that occur early in the fetal thy-
mus, encoding the TCRgd of skin lymphocytes, are not
suppressed. Of significance, either TCR expression pattern
allows development in the CD42CD82 (gd) pathway.
We have considered these and previous results for under-
standing the role of the TCR in ab versus gd lineage de-
termination. Evidence exists for an instructional model in
which successful rearrangement of TCRgd or TCRb
genes biases the decision of a precursor to become a gd or
ab lineage T cell. Of note, ab lineage T cells are depleted
of productive TCRg and -d rearrangements, suggesting
that the production of a functional TCRgd favors a gd lin-
eage decision (51–53). In addition, mice deficient for the
pTa component of the pre-TCR show an increase in the
number of gd lineage T cells, implying that normally pre-
TCR signals inhibit gd lineage development (54). Other
studies, however, have prompted speculation that gd/ab
Figure 7. The transgenic
AND TCR is expressed much
earlier than the P14 TCR in fetal
development. Thymocytes from
P14 TCR or AND TCR em-
bryos, harvested on the days in-
dicated (E13–18), were stained
for Thy 1.2, CD4, CD8, and
TCR (Va2 for P14 and Va11
for AND) and analyzed by four
color flow cytometry. Distribu-
tions, gated for total Thy1.21
thymocytes, display dual param-
eter, CD4 and CD8, or single
parameter, TCR (shaded), over-
laid with the negative control for
background fluorescence (un-
shaded). Numbers indicate the
percentage of cells within the in-
dicated gates. Data are represen-
tative of two such experiments
with similar time courses.545 Terrence et al.
lineage determination may occur before or independent of
TCR gene rearrangement (55–58). Of relevance, a few
CD41CD81 thymocytes arise in TCRb2/2 null mutant
mice (59), and these cells are enriched for in-frame TCRgd
rearrangements (60, 61), indicating that TCRgd, in some
circumstances, can promote ab development. Moreover,
CD41CD81 cells develop, although inefficiently, in TCRgd
transgenic mice when endogenous TCRb recombination is
diminished or suppressed (56, 62). Even in normal mice, a
minor population of TCRgd-bearing CD41CD81 cells has
been observed (63). Complicating the issue further are re-
ports that the majority of TCRb rearrangements are pro-
ductive in TCRgd1 T cells (51, 64). Others disagree, find-
ing that these rearrangements are predominantly out of
frame (65). Clearly, the data on this question are mixed and
the issue is unresolved.
Since a transgenic TCRab permits both gd and ab de-
velopment, our results and those of others (17, 38, 39)
could fit a model in which gd/ab fate is predetermined,
before or independent of TCR rearrangement/expression
(4, 66). In this scenario, the TCR plays no role in lineage
commitment but is needed only for survival and/or lineage
progression. While this model would not always couple the
appropriate TCR with lineage commitment, it is notewor-
thy that additional mechanisms operate to correct TCR
expression in the wrong lineage. In the ab lineage, TCRg
is downregulated at the CD41CD81 stage (67) and TCRa
rearrangement results in the deletion of the TCRd locus.
In the gd pathway, pTa is turned off (68) and TCRa rear-
rangement is not upregulated (69).
At first glance, the finding that premature expression of
TCRab can permit both a gd and ab cell fate appears to
be inconsistent with an instructional mechanism for lineage
commitment. However, one version of an instructional
model proposes that TCRgd and pre-TCR signals influ-
ence lineage commitment, but does not necessarily imply
that signaling differences are absolute or inherent in the
TCR structure. Thus, quantitative differences in TCRgd
and pre-TCR signaling could bias lineage choice. Perhaps
signals generated by the prematurely expressed transgenic
TCRab quantitatively mimic TCRgd signals. An addi-
tional possibility is that the timing of TCR expression in-
fluences the lineage decision. Recent evidence indicates
that TCRgd rearrangements occur slightly ahead of TCRb
in adult thymopoiesis (41, 42). Conceivably, these ordered
rearrangements could be coordinated with developmentally
regulated changes in TCR signal transduction such that the
earliest TCR signals promote a gd fate, whereas later TCR
Figure 8. Vg2–Jg1 gene rearrangements are suppressed in TCR1
CD42CD82 (TCRabDN) cells of AND TCR but not of P14 TCR
mice. Rearrangements are suppressed, independent of MHC haplotype, in
the TCRabDN but not the TCR1CD41CD82 subset of AND TCR
mice. Samples of 105 each of TCR1 (Va111 for AND, Va21 for P14,
TCRgd1 for G8 TCR, and TCRgd1 or TCRab1 for B6) (a)
CD42CD82, (b) CD41CD82, and (c) CD42CD81 lymph node T cells
from AND TCR/H-2b, AND TCR/H-2b (MHC class II1/2, CD41/2),
AND TCR/H-2q, P14 TCR, G8 TCR, and B6 mice were isolated by
electronic sorting. The relative frequency of Vg2–Jg1 rearrangements per
sample was determined using a PCR ELISA as described in Materials and
Methods. Bars represent the mean values (with SEs) of three individual
sorts, using a total of five to eight mice per sort.
Figure 9. In contrast to lymphoid T cells, skin dendritic
epithelial lymphocytes of AND TCR mice contain two
subsets of T cells, one bearing only the transgenic TCRab
and a second coexpressing the transgenic TCRab with en-
dogenous TCRgd. Isolated epidermal lymphocytes of (a)
H-2d AND TCR transgenic (tg) or (b) nontransgenic (non
tg) B10.D2 mice were stained for TCRab (H57-597) and
TCRgd (GL3) and analyzed by flow cytometry. The num-
bers inside the quadrant represent the percentage of cells in
each population. The data are representative of several anal-
yses of AND TCR mice of H-2d or other H-2 haplotypes.546 g/d T Cell Development in TCR-a/b Transgenic Mice
signals favor an ab fate. Our data could fit with such a se-
quential model since distinct TCR signals regulating lin-
eage choice would be generated as a function of time, ir-
respective of TCR substitutions. In some sense, this
sequential model can be seen as both predetermined and
instructional: predetermined, since changes in intracellular
TCR signals over time are developmentally prepro-
grammed, and instructional, since distinct signals mediate
lineage commitment. However, such signals are not inher-
ent to the TCR structure. In any case, the previous results
demonstrating that ab T cells are depleted of in-frame
TCRgd rearrangements (51–53) and the low frequency of
productive TCRb rearrangements in gd T cells (65) sup-
port a sequential model.
TCRab transgenic mice are widely used to study anti-
gen-specific immune responses in vivo. The studies re-
ported here should send a note of caution regarding the use
of such mice for this purpose. If, as we conclude, the trans-
genic TCRab receptor can substitute for the TCRgd in
gd lineage T cells, cells that would normally be immuno-
logically silent can now participate in an antigen-specific
response. Because gd T cells have unique developmental,
functional, and homing properties, they could contribute
to the response in nonphysiological ways. Thus, difficulties
with these mice could be related to the large number of
mature T cells expressing a single TCR, but also because
gd lineage cells (bearing transgenic TCRab) contribute to
the antigenic response in unpredictable ways. Even sorting
for CD41 cells may not help, since a few gd T cells express
CD4 (57). A new generation of TCR transgenic mice,
with delayed TCRab expression, may provide a solution
to this problem.
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